Stocks Comparison
Bristol Myers Squibb vs Pfizer: revenue, profit, margins and growth compared
Bristol Myers Squibb brought in $48.2B of revenue in fiscal 2025, Pfizer $62.6B in fiscal 2025. Revenue changed by -0.2% at Bristol Myers Squibb and -1.6% at Pfizer on the year before, so Bristol Myers Squibb grew faster. Bristol Myers Squibb kept 14.6% of its revenue as net profit, Pfizer 12.4%. Free cash flow was $12.8B at Bristol Myers Squibb and $9.1B at Pfizer.
Side by side, latest fiscal year
| BMY | PFE | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $48.2B | $62.6B |
| Revenue growth | -0.2% | -1.6% |
| Net income | $7.1B | $7.8B |
| Net margin | 14.6% | 12.4% |
| Free cash flow | $12.8B | $9.1B |
| Free cash flow margin | 26.7% | 14.5% |
| Earnings per share (diluted) | $3.46 | $1.36 |
| Cash | $10.2B | $1.1B |
| Debt | $44.8B | $64.6B |
| Price to earnings | 18.2 | 21.1 |
| Market value | $128.4B | $163.4B |
| Dividend yield | 3.96% | 6.00% |
| Rank by revenue in sector | #16 of 523 · Health care | #13 of 523 · Health care |
Over the years
Questions about Bristol Myers Squibb and Pfizer
Which is bigger by revenue, Bristol Myers Squibb or Pfizer?
Pfizer is bigger by revenue: $62.6B in fiscal 2025, against $48.2B for Bristol Myers Squibb in fiscal 2025.
Which keeps more of its revenue as profit, Bristol Myers Squibb or Pfizer?
Bristol Myers Squibb had a net margin of 14.6% in fiscal 2025; Pfizer had 12.4% in fiscal 2025.
Which grew revenue faster, Bristol Myers Squibb or Pfizer?
In their latest fiscal years revenue changed by -0.2% at Bristol Myers Squibb and -1.6% at Pfizer.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.